Literature DB >> 22847740

Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing.

Alina Daba1, Konstantinos Gkouvatsos, Giada Sebastiani, Kostas Pantopoulos.   

Abstract

The iron regulatory hormone hepcidin responds to both oral and parenteral iron. Here, we hypothesized that the diverse iron trafficking routes may affect the dynamics and kinetics of the hepcidin activation pathway. To address this, C57BL/6 mice were administered an iron-enriched diet or injected i.p. with iron dextran and analyzed over time. After 1 week of dietary loading with carbonyl iron, mice exhibited significant increases in serum iron and transferrin saturation, as well as in hepatic iron, Smad1/5/8 phosphorylation and bone morphogenetic protein 6 (BMP6), and hepcidin mRNAs. Nevertheless, hepcidin expression reached a plateau afterward, possibly due to upregulation of inhibitory Smad7, Id1, and matriptase-2 mRNAs, while hepatic and splenic iron continued to accumulate over 9 weeks. One day following parenteral administration of iron dextran, mice manifested elevated serum and hepatic iron levels and Smad1/5/8 phosphorylation, but no increases in transferrin saturation or BMP6 mRNA. Surprisingly, hepcidin failed to appropriately respond to acute overload with iron dextran, and a delayed (after 5-7 days) hepcidin upregulation correlated with increased transferrin saturation, partial relocation of iron from macrophages to hepatocytes, and induction of BMP6 mRNA. Our data suggest that the physiological hepcidin response is saturable and are consistent with the idea that hepcidin senses exclusively iron compartmentalized within circulating transferrin and/or hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847740     DOI: 10.1007/s00109-012-0937-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  34 in total

1.  Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.

Authors:  Emilio Ramos; Léon Kautz; Richard Rodriguez; Michael Hansen; Victoria Gabayan; Yelena Ginzburg; Marie-Paule Roth; Elizabeta Nemeth; Tomas Ganz
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

Review 2.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

Review 3.  Clinical use of intravenous iron: administration, efficacy, and safety.

Authors:  Michael Auerbach; Harold Ballard
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

4.  Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis.

Authors:  John D Ryan; Eleanor Ryan; Aurelie Fabre; Matthew W Lawless; John Crowe
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

5.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.

Authors:  Jodie L Babitt; Franklin W Huang; Diedra M Wrighting; Yin Xia; Yisrael Sidis; Tarek A Samad; Jason A Campagna; Raymond T Chung; Alan L Schneyer; Clifford J Woolf; Nancy C Andrews; Herbert Y Lin
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

6.  Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload.

Authors:  Gennady Ilyin; Brice Courselaud; Marie Bérengère Troadec; Christelle Pigeon; Mehdi Alizadeh; Patricia Leroyer; Pierre Brissot; Olivier Loréal
Journal:  FEBS Lett       Date:  2003-05-08       Impact factor: 4.124

7.  Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.

Authors:  Daniel F Wallace; Lesa Summerville; Emily M Crampton; David M Frazer; Gregory J Anderson; V Nathan Subramaniam
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

8.  SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression.

Authors:  Katarzyna Mleczko-Sanecka; Guillem Casanovas; Anan Ragab; Katja Breitkopf; Alexandra Müller; Michael Boutros; Steven Dooley; Matthias W Hentze; Martina U Muckenthaler
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

9.  A method to assess 59Fe in residual tissue blood content in mice and its use to correct 59Fe-distribution kinetics accordingly.

Authors:  Klaus Schümann; Bernadett Szegner; Birgit Kohler; Michael W Pfaffl; Thomas Ettle
Journal:  Toxicology       Date:  2007-08-07       Impact factor: 4.221

10.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

View more
  18 in total

1.  Mice are poor heme absorbers and do not require intestinal Hmox1 for dietary heme iron assimilation.

Authors:  Carine Fillebeen; Konstantinos Gkouvatsos; Gabriela Fragoso; Annie Calvé; Daniel Garcia-Santos; Marzell Buffler; Christiane Becker; Klaus Schümann; Prem Ponka; Manuela M Santos; Kostas Pantopoulos
Journal:  Haematologica       Date:  2015-05-14       Impact factor: 9.941

2.  Rapid elevation of transferrin saturation and serum hepcidin concentration in hemodialysis patients after intravenous iron infusion.

Authors:  Natalia Kitsati; Dimitrios Liakos; Eleni Ermeidi; Michalis D Mantzaris; Spyros Vasakos; Eleni Kyratzopoulou; Petros Eliadis; Emilios Andrikos; Elisavet Kokkolou; Georgios Sferopoulos; Avgi Mamalaki; Konstantinos Siamopoulos; Dimitrios Galaris
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

3.  Assessment of MR-based R2* and quantitative susceptibility mapping for the quantification of liver iron concentration in a mouse model at 7T.

Authors:  Gregory Simchick; Zhi Liu; Tamas Nagy; May Xiong; Qun Zhao
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

4.  Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease.

Authors:  Edwin Patino; Stephen B Doty; Divya Bhatia; Kelly Meza; Yuan-Shan Zhu; Stefano Rivella; Mary E Choi; Oleh Akchurin
Journal:  Kidney Int       Date:  2020-06-20       Impact factor: 10.612

5.  A crosstalk between hepcidin and IRE/IRP pathways controls ferroportin expression and determines serum iron levels in mice.

Authors:  Edouard Charlebois; Carine Fillebeen; Angeliki Katsarou; Aleksandr Rabinovich; Kazimierz Wisniewski; Vivek Venkataramani; Bernhard Michalke; Anastasia Velentza; Kostas Pantopoulos
Journal:  Elife       Date:  2022-09-06       Impact factor: 8.713

6.  Iron Loading Exaggerates the Inflammatory Response to the Toll-like Receptor 4 Ligand Lipopolysaccharide by Altering Mitochondrial Homeostasis.

Authors:  Konrad Hoeft; Donald B Bloch; Jan A Graw; Rajeev Malhotra; Fumito Ichinose; Aranya Bagchi
Journal:  Anesthesiology       Date:  2017-07       Impact factor: 7.892

Review 7.  Animal Models of Normal and Disturbed Iron and Copper Metabolism.

Authors:  Xiaoyu Wang; Michael D Garrick; James F Collins
Journal:  J Nutr       Date:  2019-12-01       Impact factor: 4.798

8.  Iron-dependent regulation of hepcidin in Hjv-/- mice: evidence that hemojuvelin is dispensable for sensing body iron levels.

Authors:  Konstantinos Gkouvatsos; Carine Fillebeen; Alina Daba; John Wagner; Giada Sebastiani; Kostas Pantopoulos
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

9.  Dietary iron concentration may influence aging process by altering oxidative stress in tissues of adult rats.

Authors:  Lorena Fernandes Arruda; Sandra Fernandes Arruda; Natália Aboudib Campos; Fernando Fortes de Valencia; Egle Machado de Almeida Siqueira
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

10.  The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overload.

Authors:  Zachary J Hawula; Eriza S Secondes; Daniel F Wallace; Gautam Rishi; V Nathan Subramaniam
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.